登录

Tus-Harvest Biotech Raises ¥27M in Series A Financing

作者: Mailman 2020-02-07 17:26
启迪禾美
http://www.agecode.net
企业数据由 动脉橙 提供支持
护肤品研发商 | A轮 | 运营中
中国-浙江
2020-01-20
融资金额:RMB¥2700万
启融创投
查看

According to 36Kr.com, Tus-Harvest Biotech Co. Ltd. ("Tus-Harvest Biotech") has closed its ¥27 million Series A round of financing, led by PICC Qidi Fund (founded by PICC and Qidi Technology), with participation from Qirong Venture Capital and 36Kr MINIPO. Proceeds of this financing will be used for the R&D of innovative bioactive peptide technology, the construction of the Aging Science Innovation Lab and the brand building based on the bioactive peptide. 


So far, Tus-Harvest Biotech has completed three rounds of financing, with a total funding amount of nearly 50 million yuan.


Founded in March 2018 and headquartered at the Yangtze Delta Region Institute of Tsinghua University, Zhejiang, Tus-Harvest Biotech has an overall layout of the medium and high-end health industry targeting the terminal market. Tus-Harvest Biotech's age-fighting brand CordMagic is the success of years of research in cell biology and 6 years of specialized joint studies. 


Through technical innovation and resource integration, Tus-Harvest Biotech focuses on providing the raw materials of high performance bioactive peptide, and comprehensive solutions for personal care products and health care products based on the bioactive peptide, including effective skincare, scalp care products, and intestinal conditioners.


Tus-Harvest Biotech is committed to technological innovation and has built a proprietary platform that can independently develop bioactive peptide raw materials, which gives it advantages in market competition with good expansibility The platform provides a favorable foundation for the product transformation and brand building in the downstream of the industry. The technical layout of its Aging Innovation Lab has overcome the situation that the bioactive peptide raw materials at home and abroad are mainly imitation.


>>>>

About PICC Qidi Fund

 

Founded in 2016 and headquartered in Ningbo Hangzhou Bay New Area, PICC Qidi Fund is managed by PICC Industrial Investment Management Company. It focuses on investment in health care, energy conservation, environmental protection, and information security.


>>>>

About Qirong Venture Capital


Founded in September 2015, Qirong Venture Capital is an investment firm, focusing on equity investment in the medical industry.

相关赛道 保健品及其它
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

【首发】盈嘉合生完成数千万元A轮融资,加快在合成生物学领域的布局

流动性退潮倒计时?生物科技企业冲刺IPO

Boohee Closes Series C Funding Round, Led by Fosun International

Microphyt筹资2850万欧元,开发天然微藻保健产品

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

【生物医药日报】瑞德西韦在武汉“显效”系谣言;三家生物医药企业同日登陆纳斯达克,首日均收涨

2020-02-07
下一篇

Stemirna Therapeutics Snares ¥10 million in Series A+ Round from Junshi Biosciences, Providing mRNA Vaccines

2020-02-07